loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2020_158___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Zhejiang Liaoyuan Pharmaceutical Co LTD

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Duqiao Town CN (1)

    filter

    01 Mirtazapine, Anhydrous (1)

    filter

    01 China (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Zhejiang Liaoyuan Pharmaceutical Co...

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mirtazapine, Anhydrous

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2020-158 - Rev 01
    Valid
    Chemical
    2023-02-08
    2338
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2020-158 - Rev 01 of Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Duqiao Town Cn

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2020-158 - Rev 01 of Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Duqiao Town Cn 1

    20

    Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Duqiao Town Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Mirtazapine, Anhydrous, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-158 - Rev 01

    This Chemical Type CEP, issued on February 08, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2338 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY